An unfortunate choice of reference category can give additional lack of precision and obscure the interpretation of risk estimates. A highlighted odds ratio (OR) in the HAPO study is the OR for birth weight > 90(th) percentile for women in the highest compared to the lowest BMI category (“”obese class III”" versus “”underweight”"). This estimate was OR = 4.55 and OR = 3.52, with two different multiple logistic regression models. When using the “”normal weight”" category as the reference, our corresponding estimates were OR = 2.03 and OR = 1.62, respectively. www.selleckchem.com/products/GSK690693.html Moreover, our choice of reference category also gave narrower confidence intervals.
Summary: Due to several methodological
drawbacks, categorisation should be avoided. Modern statistical analyses should be used to analyse continuous exposure data, and to explore non-linear relations. If continuous data are categorised, special
attention must be given to the choice of reference category.”
“Background: The noninvasive evaluation of nigrostriatal dopaminergic integrity by PET can provide useful information for the differential diagnosis Z-VAD-FMK chemical structure between dementia with Lewy bodies (DLB) and Alzheimer’s disease (AD). Objectives: To evaluate the diagnostic potential of imaging striatal monoaminergic terminal integrity with the novel vesicular monoamine transporter type 2 (VMAT2) radioligand [F-18]AV-133 and PET to distinguish DLB from AD. Methods: Fifty participants [9 DLB, 11 AD, 20 Parkinson's disease (PD) and 10 healthy age-matched control subjects (HC)] underwent [F-18]AV-133 PET studies. Additionally, 20 participants underwent amyloid imaging PET scans with either [C-11]PiB or F-18-florbetaben. VMAT2 density was calculated through normalized tissue uptake value ratios (R-T) at 120-140 min after injection using the primary visual or the cerebellar cortex as reference region. Comparison of the R T for [F-18]AV-133 was done between the different clinical diagnostic groups. Results: Significantly lower striatal VMAT2 densities were observed in DLB and PD when compared to AD and
GSK923295 datasheet HC, especially in the posterior putamen. In contrast to PD and DLB, no reductions were observed in AD patients when compared to HC. Conclusions: [F-18] AV-133 allows assessment of nigrostriatal degeneration in Lewy body diseases. In contrast to amyloid imaging, VMAT2 imaging with [F-18]AV-133 can robustly detect reductions of dopaminergic nigrostriatal afferents in DLB patients, assisting in the differential diagnosis from AD. Copyright (C) 2012 S. Karger AG, Basel”
“A novel fabrication has been employed to produce nanocelluloses from natural fibers (hemp) and the developed nanocellulose was then used as “”coupling agent”" to modify hemp fibers themselves.
The size distribution of nano-particles (nanocellulose) was measured by nanoparticle tracking analysis (NTA). Results showed that the oxidation-sonication developed nanocellulose had wider size range (29-281 nm) and the average size (100-112 nm).